Target intelligence / Profile preview

UBR5 divergent transcript (UBR5-DT)

Target
UBR5-DT
Molecular classification
Other (Non-coding RNA gene)
01

Overview

UBR5-DT is an RNA gene located at the UBR5 genomic locus, designated as the "divergent transcript" due to its orientation and transcription relative to the main UBR5 gene. It is classified as a non-coding RNA (ncRNA) with no established protein product or well-defined biological functions, disease roles, or drug interactions. There is currently no evidence that UBR5-DT itself is a therapeutic target, nor is it recognized as a receptor, enzyme, transporter, or similar molecular entity. The query target "UBR5 divergent transcript" is not a canonical target molecule/receptor such as an enzyme or receptor protein. It is a non-coding RNA gene with undefined biological roles and is not considered a standard drug target. There are no data supporting "UBR5-DT" as a valid entry for molecular classification frameworks applied to therapeutic targets; it is therefore marked as "is_incorrect: true." If structured cataloging of therapeutic targets is intended, "UBR5-DT" should be excluded or noted as a non-target, and further clarification may be needed regarding any potential biological relevance or function, which remains unreported in current sources.

Other names
UBR5 divergent transcriptUBR5-DT
02

Biological functions

Unknown; no established direct biological function reported for UBR5-DT
03

Disease associations

Unknown

Beyond the preview

Go deeper on UBR5 divergent transcript (UBR5-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on UBR5 divergent transcript (UBR5-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call